AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMIKACIN SULFATE
7 registrations across 3 African markets— 6 active
Markets with AMIKACIN SULFATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMIKACIN SULPHATE INJECTION (Each 2ml contains Amikacin Sulfate 500mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| AMIKACIN SULPHATE INJECTION (Each 2ml contains Amikacin Sulfate 500mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| MIKACIN 500MG/2ML INJECTION INJECTION | 🇲🇼Malawi | — | expired | Apr 2004 |
| AMIKACIN SULFATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | LABORATE PHARMACEUTICA LS INDIA LIMITED | active | — |
| AMIKACIN SULFATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | LABORATE PHARMACEUTICA LS INDIA LIMITED | active | — |
| AMIKACIN SULFATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
| AMIKACIN SULFATE PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | ROYAL PHARMA 2011 LIMITED | active | — |
AMIKACIN SULFATE in Africa — Regulatory Overview
AMIKACIN SULFATE is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Malawi. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 6 (86%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.